Skip to main content

News

June 15, 2020
Targeted chemo is feasible, safe, and may improve quality of life.
August 07, 2018
Liver resection was found to have significant survival benefits over TACE in patients with Barcelona Clinic Liver Cancer stage B hepatocellular carcinoma.
July 31, 2018
In a recent systemic review and meta-analysis, researchers evaluated preoperative strategies for their ability to effectively increase resectability rates in HCC.
July 26, 2018
A commercially available 3-dimensional (3D) workstation and liver analysis software can be useful for estimating the embolic area in conventional transarterial chemoembolization for hepatocellular carcinoma.
July 24, 2018
A recent study compared outcomes for thermal ablation versus nephrectomy for renal cell carcinoma.
July 17, 2018
Some patients with unresectable hepatocellular carcinoma (HCC) have prolonged survival after treatment with yttrium-90 radioembolization.
July 11, 2018
The study assessed whether patients with unresectable ICC can benefit from transarterial Y-90 glass microsphere radioembolization.
July 10, 2018
Researchers conducted a prospective, single-center, double-blind randomized phase III trial that compared stable and unstable water-in-oil emulsions for chemoembolization.
June 28, 2018
The study compared results for patients with caudate HCC who were treated with RFA vs TACE.
June 26, 2018
The combination of sorafenib and transarterial chemoembolization (TACE) for patients with advanced HCC seems feasible and promising, researchers reported.
June 15, 2018
Percutaneous cryoblation ablation may be a reasonable treatment option for patients with clinical stage T1a papillary on renal cell carcinoma (pRCC) and clear-cell RCC (ccRCC), especially for patients with (pRCC).
Back to Top